InsiderTrades

Form 4 for EW Edwards Lifesciences

Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-13 · accession 0001225208-22-012623 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-12-13 2022-12-13 EW Wood Larry L CVP, TAVR S - Sale+OE $76.98 -7,236 202.2K -3% -$557.0K
D 2022-12-13 2022-12-13 EW Wood Larry L CVP, TAVR M - OptEx $36.75 +7,236 209.5K +4% +$265.9K
D 2022-12-13 2022-12-13 EW Wood Larry L CVP, TAVR M - OptEx $0.00 -7,236 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-12-13 S D 300 $77.48 209,167.80 D — — (F2) This transaction was executed in multiple trades at prices ranging from $77.43 to $77.55. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
2 Common Common Stock 2022-12-13 M A 7,236 $36.75 209,467.80 D — —
3 Common Common Stock 2022-12-13 S D 6,936 $76.96 202,231.80 D — — (F3) This transaction was executed in multiple trades at prices ranging from $76.43 to $77.40. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
4 Derivative Employee Stock Option (Right to Acquire) 2022-12-13 M D 7,236 $0.00 0 D $36.75 · 2018-05-11 to 2024-05-10 7,236 Common Stock